Published in Aliment Pharmacol Ther on March 18, 2014
Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis (2014) 1.96
Inflammatory bowel disease as a model for translating the microbiome. Immunity (2014) 1.39
Letter: Faecal microbiota transplantation--not a one-size-fits-all approach. Aliment Pharmacol Ther (2014) 1.07
Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol (2016) 1.02
Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther (2015) 1.01
Recurrent Clostridium difficile infection: From colonization to cure. Anaerobe (2015) 1.00
Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem? Front Microbiol (2016) 0.90
Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clin Endosc (2016) 0.90
Fecal microbiota transplantation for the management of Clostridium difficile infection. Infect Dis Clin North Am (2015) 0.88
Systematic Review: Adverse Events of Fecal Microbiota Transplantation. PLoS One (2016) 0.87
Experimental design considerations in microbiota/inflammation studies. Clin Transl Immunology (2016) 0.87
IBS-like symptoms in patients with ulcerative colitis. Clin Exp Gastroenterol (2015) 0.86
Fecal microbiota transplantation for the treatment of Clostridium difficile infection. J Hosp Med (2015) 0.85
Bugging inflammation: role of the gut microbiota. Clin Transl Immunology (2016) 0.84
Pathogenesis of Crohn's disease. F1000Prime Rep (2015) 0.81
Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.79
Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2016) 0.79
Towards large-cohort comparative studies to define the factors influencing the gut microbial community structure of ASD patients. Microb Ecol Health Dis (2015) 0.79
Clinical efficacy maintains patients' positive attitudes toward fecal microbiota transplantation. Medicine (Baltimore) (2016) 0.78
Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis. PLoS One (2016) 0.77
Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail. Mucosal Immunol (2016) 0.76
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes (2017) 0.75
Coordinated Hospital-Home Fecal Microbiota Transplantation via Percutaneous Endoscopic Cecostomy for Recurrent Steroid-Dependent Ulcerative Colitis. Gut Liver (2016) 0.75
Human microbiome: From the bathroom to the bedside. World J Gastrointest Pathophysiol (2015) 0.75
Inventory of a reservoir: friends & foes. Indian J Med Res (2015) 0.75
Fecal Microbiota Therapy for Clostridium difficile Infection: A Health Technology Assessment. Ont Health Technol Assess Ser (2016) 0.75
Fulfilling the Promise of Microbiomics to Revolutionize Medicine. J Microbiol Exp (2015) 0.75
Dysbiosis in Crohn's disease - Joint action of stochastic injuries and focal inflammation in the gut. Gut Microbes (2017) 0.75
Letter: Faecal microbiota transplantation--not a one-size-fits-all approach; authors' reply. Aliment Pharmacol Ther (2014) 0.75
The Microbiome and Sustainable Healthcare. Healthcare (Basel) (2015) 0.75
The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure? Front Pediatr (2017) 0.75
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell (1993) 33.20
Targeted destabilization of HY5 during light-regulated development of Arabidopsis. Nature (2000) 7.43
Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med (1982) 7.14
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
Saturated molecular map of the rice genome based on an interspecific backcross population. Genetics (1994) 6.22
Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control. Mol Cell Biol (1998) 5.66
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
COP1, an Arabidopsis regulatory gene, encodes a protein with both a zinc-binding motif and a G beta homologous domain. Cell (1992) 5.58
Automaticity of social behavior: direct effects of trait construct and stereotype-activation on action. J Pers Soc Psychol (1996) 5.56
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature (2000) 5.55
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest (2001) 4.98
Seasonal and spatial variability of bacterial and archaeal assemblages in the coastal waters near Anvers Island, Antarctica. Appl Environ Microbiol (1998) 4.85
Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science (2001) 4.82
The GA5 locus of Arabidopsis thaliana encodes a multifunctional gibberellin 20-oxidase: molecular cloning and functional expression. Proc Natl Acad Sci U S A (1995) 4.80
MAP kinases. Chem Rev (2001) 4.70
Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut (1989) 4.59
Molecular interaction between COP1 and HY5 defines a regulatory switch for light control of Arabidopsis development. Mol Cell (1998) 4.10
Single-molecule fluorescence spectroscopy of enzyme conformational dynamics and cleavage mechanism. Proc Natl Acad Sci U S A (1999) 4.05
Scalable and expressive medical terminologies. Proc AMIA Annu Fall Symp (1996) 4.03
YidC mediates membrane protein insertion in bacteria. Nature (2000) 4.01
Synapse-specific, long-term facilitation of aplysia sensory to motor synapses: a function for local protein synthesis in memory storage. Cell (1997) 3.93
Visual acuity and quality of life in patients with cataract in Doumen County, China. Ophthalmology (1999) 3.82
A novel europium(III)-based MRI contrast agent. J Am Chem Soc (2001) 3.71
Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother (2001) 3.62
Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol Cell (1999) 3.58
A mutant of TTX-resistant cardiac sodium channels with TTX-sensitive properties. Science (1992) 3.47
Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol (1985) (2000) 3.37
The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci U S A (2000) 3.32
Arabidopsis bZIP protein HY5 directly interacts with light-responsive promoters in mediating light control of gene expression. Plant Cell (1998) 3.25
Automated detection of Haemophilus influenzae. Appl Microbiol (1973) 3.16
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science (2000) 3.12
Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev (1999) 3.07
Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res (1999) 2.99
Language dominance in partial epilepsy patients identified with an fMRI reading task. Neurology (2002) 2.98
Phenotypic analysis of genes encoding yeast zinc cluster proteins. Nucleic Acids Res (2001) 2.87
Global gene expression profiles of Bacillus subtilis grown under anaerobic conditions. J Bacteriol (2000) 2.77
A transient, neuron-wide form of CREB-mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis. Cell (1999) 2.77
Aplysia CREB2 represses long-term facilitation: relief of repression converts transient facilitation into long-term functional and structural change. Cell (1995) 2.75
Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J Infect Dis (1994) 2.72
The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet (2001) 2.71
Variation in breast cancer surgery in Ontario. CMAJ (1994) 2.70
The COP9 complex, a novel multisubunit nuclear regulator involved in light control of a plant developmental switch. Cell (1996) 2.70
Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol (1996) 2.68
Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Infect Dis (1992) 2.60
Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol (2000) 2.54
GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc Natl Acad Sci U S A (2006) 2.53
The effect of the Taiwan motorcycle helmet use law on head injuries. Am J Public Health (2000) 2.49
Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis. Obes Rev (2009) 2.49
Tumor therapy with targeted atomic nanogenerators. Science (2001) 2.48
The fall and rise of carotid endarterectomy in the United States and Canada. N Engl J Med (1998) 2.48
A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol (2000) 2.46
Influence of CH4 production by Methanobacterium ruminantium on the fermentation of glucose and lactate by Selenomonas ruminantium. Appl Environ Microbiol (1977) 2.43
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res (2000) 2.39
Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes (1998) 2.34
Grass genomes. Proc Natl Acad Sci U S A (1998) 2.33
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
LAI inversion algorithm based on directional reflectance kernels. J Environ Manage (2006) 2.31
The Cdc6p nucleotide-binding motif is required for loading mcm proteins onto chromatin. Proc Natl Acad Sci U S A (1999) 2.28
A human mitochondrial transcriptional activator can functionally replace a yeast mitochondrial HMG-box protein both in vivo and in vitro. Mol Cell Biol (1993) 2.27
MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene (2010) 2.23
A survey of blindness and cataract surgery in Doumen County, China. Ophthalmology (1999) 2.15
The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci (2001) 2.15
Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem (1995) 2.15
Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron (1998) 2.13
Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro. Mol Biol Cell (1993) 2.11
An alternative to serum for cultivation of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg (1997) 2.11
Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest (1991) 2.11
High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion. Br J Dermatol (2014) 2.09
Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res (2002) 2.08
Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience (2004) 2.02
Social networks, social support, and mortality among older people in Japan. J Gerontol (1994) 2.01
Telepathology overview: from concept to implementation. Hum Pathol (2001) 2.01
IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2002) 2.01
Leisure activity and risk of cognitive impairment: the Chongqing aging study. Neurology (2005) 2.00
Mutation in the phosphorylation sites of MAP kinase blocks learning-related internalization of apCAM in Aplysia sensory neurons. Neuron (1997) 1.98
Development of a smoking prevention mass media program using diagnostic and formative research. Prev Med (1988) 1.97
Interleukin 2 receptor expression by macrophages in inflammatory bowel disease. Clin Exp Immunol (1988) 1.95
Spatial scaling between leaf area index maps of different resolutions. J Environ Manage (2006) 1.93
A simple filtration method to remove plankton-associated Vibrio cholerae in raw water supplies in developing countries. Appl Environ Microbiol (1996) 1.93
Direct measurement of the 7Be solar neutrino flux with 192 days of borexino data. Phys Rev Lett (2008) 1.93
Auditory comprehension of language in young children: neural networks identified with fMRI. Neurology (2003) 1.91
Measurement of the rate of nu(e) + d --> p + p + e(-) interactions produced by (8)B solar neutrinos at the Sudbury Neutrino Observatory. Phys Rev Lett (2001) 1.88
Modelling the control strategies against dengue in Singapore. Epidemiol Infect (2007) 1.86
Statistical methods for expression quantitative trait loci (eQTL) mapping. Biometrics (2006) 1.85
FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine (1999) 1.83
Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. J Neurosci (2001) 1.81
Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci U S A (1997) 1.78
A prediction model for type 2 diabetes risk among Chinese people. Diabetologia (2008) 1.78
Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation. Am J Transplant (2012) 1.78
The antileishmanial activity of novel oxygenated chalcones and their mechanism of action. J Antimicrob Chemother (1999) 1.77
Images of cone photoreceptors in the living human eye. Vision Res (1996) 1.76
Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet (1995) 1.75
Turnip crinkle virus genes required for RNA replication and virus movement. Virology (1992) 1.75
MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene (2012) 1.74
Combinatorial interplay of promoter elements constitutes the minimal determinants for light and developmental control of gene expression in Arabidopsis. EMBO J (1996) 1.74
1H and (17)O NMR detection of a lanthanide-bound water molecule at ambient temperatures in pure water as solvent. Inorg Chem (2001) 1.70
Homology in accessory proteins of replicative polymerases--E. coli to humans. Nucleic Acids Res (1993) 1.70
Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. J Med Chem (1999) 1.70
Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med (1995) 1.69